STOCK TITAN

Blueprint Medicines to Present at Upcoming Investor Conferences

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Blueprint Medicines Corporation (NASDAQ: BPMC) has announced its participation in several upcoming investor conferences. These include:

  • Jefferies Virtual Healthcare Conference on June 1, 2021, at 4:30 p.m. ET.
  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 8:50 a.m. ET.
  • JMP Securities Life Sciences Conference on June 16, 2021, at 1:00 p.m. ET.

Live webcasts will be available on the company's website, with replays accessible for 30 days post-presentation.

Loading...
Loading translation...
Argus Session date unavailable
+0.64% session move Open Argus
Details

News Market Reaction – BPMC

The recorded move for BPMC in the trading session of this news was +0.64%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CAMBRIDGE, Mass., May 25, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced its participation in the following upcoming investor conferences.

  • Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:30 p.m. ET.
  • Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 8:50 a.m. ET.
  • JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 1:00 p.m. ET.

A live webcast of each presentation will be available by visiting the Investors & Media section of Blueprint Medicines' website at http://ir.blueprintmedicines.com. A replay of the webcasts will be archived on Blueprint Medicines' website for 30 days following each presentation.

About Blueprint Medicines

Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines to patients in the United States and Europe, and we are globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.  For more information, visit www.BlueprintMedicines.com and follow us on Twitter (@BlueprintMeds) and LinkedIn.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-upcoming-investor-conferences-301298404.html

SOURCE Blueprint Medicines Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the schedule of upcoming investor conferences for BPMC?

Blueprint Medicines will present at the Jefferies Virtual Healthcare Conference on June 1, 2021, at 4:30 p.m. ET, Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 8:50 a.m. ET, and JMP Securities Life Sciences Conference on June 16, 2021, at 1:00 p.m. ET.

How can I watch the live webcasts for Blueprint Medicines' presentations?

Live webcasts for BPMC's upcoming presentations can be accessed via the Investors & Media section of their website.

Will the presentations by BPMC be available for replay?

Yes, a replay of each presentation will be available on the BPMC website for 30 days after the live event.

What is the focus of Blueprint Medicines Corporation?

Blueprint Medicines is a global precision therapy company dedicated to inventing life-changing medicines for cancer and hematologic disorders.

What is Blueprint Medicines' stock symbol?

The stock symbol for Blueprint Medicines is BPMC.

Keep reading